Cerenome, Inc. (CNSY)
0.6427
-0.03
(-4.06%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
+0.02
(+2.71%)
After-Hours: 20:00
Cerenome Net Income (TTM) : -26.09M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.09M |
| March 31, 2026 | -15.89M |
| December 31, 2025 | -26.35M |
| September 30, 2025 | -24.54M |
| June 30, 2025 | -22.99M |
| March 31, 2025 | -27.12M |
| December 31, 2024 | -12.98M |
| September 30, 2024 | -12.88M |
| June 30, 2024 | -13.23M |
| March 31, 2024 | -11.77M |
| December 31, 2023 | -13.32M |
| September 30, 2023 | -15.16M |
| June 30, 2023 | -17.16M |
| March 31, 2023 | -20.96M |
| December 31, 2022 | -20.28M |
| September 30, 2022 | -18.77M |
| June 30, 2022 | -17.28M |
| March 31, 2022 | -14.80M |
| December 31, 2021 | -13.40M |
| September 30, 2021 | -12.83M |
| June 30, 2021 | -10.84M |
| March 31, 2021 | -9.874M |
| December 31, 2020 | -8.241M |
| September 30, 2020 | -3.734M |
| June 30, 2020 | -1.48M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.908M |
| December 31, 2019 | -3.285M |
| September 30, 2019 | -6.215M |
| June 30, 2019 | -8.137M |
| March 31, 2019 | -8.155M |
| December 31, 2018 | -10.10M |
| September 30, 2018 | -16.35M |
| June 30, 2018 | -19.76M |
| March 31, 2018 | -23.53M |
| December 31, 2017 | -26.66M |
| September 30, 2017 | -23.32M |
| June 30, 2017 | -23.90M |
| March 31, 2017 | -24.25M |
| December 31, 2016 | -22.05M |
| September 30, 2016 | -19.88M |
| June 30, 2016 | -12.97M |
| March 31, 2016 | -2.118M |
| December 31, 2015 | -19.40M |
| September 30, 2015 | -23.57M |
| June 30, 2015 | -34.48M |
| March 31, 2015 | -50.76M |
| December 31, 2014 | -38.54M |
| September 30, 2014 | -41.65M |
| June 30, 2014 | -37.53M |
| March 31, 2014 | -28.91M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.724B |
| Ernexa Therapeutics, Inc. | -12.26M |
| ACADIA Pharmaceuticals, Inc. | 362.23M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |